Skip to content
value.today

Iconic Therapeutics Inc.

Total raised
$75 M
3 rounds on record
Latest round
$13 M
Apr 2019
First round on record
Apr 2014
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Iconic Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2019$13 MNo. 3$10 to $50 million

Iconic Therapeutics Inc.: Raise no. 3, Apr 2019

Investors in this round

37 investors had bought by the notice of Apr 26, 2019: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $16 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Ser B Prime Pref Stk; also includes Ser A Prime Pref Stk issued in exchg for shares of Com Stk issued upon conversion of shares of prior Pref Stk in a mandatory conversion effective as of immediately
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • William Greene · Executive Officer, Director
  • Bruce Cohen · Director
  • Bruce Robertson · Director
  • Julia Gregory · Director
  • Kirk Dornbush · Director
  • Peter Hirth · Director
  • Todd Foley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Consists of cash in the agg amount of $2,809,459.40 and cancellation of principal and accrued interest due under outstanding promissory notes in the agg amount of $8,770,675.44 which was converted at a discounted price into $10,221,565.00 of shares.”
  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”

Signed by William L. Greene, Ceo. Source: SEC Form D, newest notice filed Apr 26, 2019. Read the notice at the SEC.

equitySEC
Dec 2015$49 MNo. 2$10 to $50 million

Iconic Therapeutics Inc.: Raise no. 2, Dec 2015

Investors in this round

11 investors had bought by the notice of Nov 2, 2016: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$49 M of $49 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series C-1 Preferred Stock; Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kirk Dornbush · Executive Officer, Director
  • William Greene · Executive Officer, Director
  • Bruce Robertson · Director
  • Johan Kordel · Director
  • Peter Hirth · Director
  • Todd Foley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”

Signed by William L. Greene, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Nov 2, 2016. Read the notice at the SEC.

equitySEC
Apr 2014$13 MNo. 1$10 to $50 million

Iconic Therapeutics Inc.: Raise no. 1, Apr 2014

Investors in this round

40 investors had bought by the notice of Apr 23, 2014: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $24 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: (1) Series B-1 Preferred Stock; Common Stock issuable upon conversion and (2) Series A-1 Preferred Stock; Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$216,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kirk Dornbush · Executive Officer, Director
  • William Greene · Executive Officer, Director
  • Bruce Robertson · Director
  • Johan Kordel · Director
  • Jon Soderstrom · Director
  • Todd Foley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”

Signed by Kirk Dornbush, President. Source: SEC Form D, newest notice filed Apr 23, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Iconic Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2019).

    SEC Form D · Apr 2019

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2019

That is all the official record says: Iconic Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Iconic Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 40 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Iconic Therapeutics Inc.
NameRoleNamed in
William GreeneExecutive officerApr 2019
Kirk DornbushExecutive officerNov 2016
Bruce CohenDirectorApr 2019
Bruce RobertsonDirectorApr 2019
Julia GregoryDirectorApr 2019
Kirk DornbushDirectorApr 2019
Peter HirthDirectorApr 2019
Todd FoleyDirectorApr 2019
William GreeneDirectorApr 2019
Johan KordelDirectorNov 2016
Jon SoderstromDirectorApr 2014